Tamayo Louis Edward — SEC insider filings

SEC reporting owner CIK 2083206. 6 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2025-09-03 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lexeo Therapeutics, Inc. (LXEO)Chief Financial Officer6—3 legs · 9,765 sh · $44,3236

Insider filings — Tamayo Louis Edward

FiledFormIssuerReported transactionsSource
2026-11-184Lexeo Therapeutics, Inc. (LXEO)Sale (S): 1,007 @ $3.26EDGAR
2026-09-284Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 54,750 (derivative) @ $0EDGAR
2026-08-194Lexeo Therapeutics, Inc. (LXEO)Sale (S): 4,117 @ $4.91EDGAR
2026-07-014Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 12,000 @ $0 · Sale (S): 4,641 @ $4.49EDGAR
2026-02-064Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 44,665 @ $0 · Grant/award (A): 226,665 (derivative) @ $0EDGAR
2025-09-034Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 45,000 @ $0 · Grant/award (A): 280,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2083206 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs